We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AMP:ASXAMP Limited Analysis

Data as of 2026-06-20 - not real-time

A$1.56

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock trades at a price‑to‑earnings multiple that is nearly double the industry average, indicating it may be overvalued despite a favorable forward PE. RSI sits just above the midpoint, suggesting neutral momentum, while the 20‑day SMA is marginally above the 50‑day SMA, hinting at a slight short‑term upward bias. However, the MACD histogram has turned negative, signaling emerging bearish pressure. Volatility over the past 30 days exceeds 25%, highlighting notable price swings, yet the beta below one points to lower systematic risk relative to the broader market. Liquidity remains solid with stable trading volume, supporting ease of entry and exit. The company carries a massive debt load relative to equity, pushing the debt‑to‑equity ratio into the high hundreds, which weighs on the balance sheet.
Operating margins are healthy, but operating cash flow is negative, raising concerns about cash conversion. No dividend is being paid, removing income appeal for yield‑focused investors. Analyst consensus leans toward a buy, with a median target modestly above current levels, suggesting perceived upside. The upside/downside estimate points to modest upside potential, while the fear‑greed index sits in the extreme greed zone, indicating bullish sentiment may be overstretched.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD crossover
  • Neutral RSI and price near support
  • High valuation relative to peers

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE suggests significant upside
  • Analyst price targets above current price
  • Stable liquidity and moderate beta

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong operating margins offset by negative cash flow
  • Heavy debt load limiting financial flexibility
  • Diversified financial services franchise in Australia and New Zealand

Key Metrics & Analysis

Financial Health

Profit Margin4.76%
P/E Ratio31.2
ROE3.60%
ROA3.11%
Debt/Equity791.59
P/B Ratio1.1
Op. Cash FlowA$-1375000064
Free Cash FlowA$150.2M
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI52.7
SupportA$1.46
ResistanceA$1.63
MA 20A$1.56
MA 50A$1.51
MA 200A$1.59
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Target PriceA$1.69
Upside/Downside8.46%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.69
Volatility27.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.